Market contribution of the products anticipated to be launched in the future has been calculated based on the historical analysis of the products. This analysis has been supported by proxy factors, such as innovation scale of the companies, status of funding, collaborations, and customer base. The scope of availability of a product in a particular region has been assessed based on comprehensive analysis of the companies’ future prospects, the regional end user perception, and other factors impacting the launch of a product in that region.

Immunoproteins are blood proteins with immunological activity, capable of affecting or changing the functioning of immune system. This property of immunoproteins serves as an indicator for diagnosing numerous infectious and chronic diseases, thereby increasing the demand for immunoprotein diagnostic tests carried out across laboratories and hospitals in the world. The immunoprotein diagnostic testing report provides market dynamics and global trends related to the immunoprotein diagnostic testing market. In addition, it presents the market estimations and forecast. The study estimates revenues that are confined to the sales of immunoprotein assays and kits used in diagnosis of diseases. However, the market estimates do not include revenue generated from the post-sale services of the assays & kits and doctor consultation fees.

The global hereditary genetic testing market is undergoing a significant flux with regard to the advancements that have already taken place and are currently invading the market space. Additionally, with the emergence genetic testing, there is immense potential for these emerging submarkets to continue to propel the overall hereditary genetic testing market. This chapter reviews the significant drivers and restraints that are considerably impacting the dynamicity of the global hereditary genetic testing market.

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure. This procedure is performed for treating kidney disorders and is classified into 2 types: hemodialysis and peritoneal dialysis. In hemodialysis, blood is pumped out of blood vessels and is purified with the help of dialyzer and then returned back to the body through vascular access. In peritoneal dialysis, the principle of the procedure remains same, however the inner lining of stomach called peritoneum is used as a filter to purify blood. This report includes the revenue generated from sales of all devices and consumables used for hemodialysis and peritoneal dialysis procedures. However, it excludes hemodialysis and peritoneal dialysis services revenue. The valuations comprise revenue generated from hemodialysis and peritoneal dialysis devices and consumables such as dialyzer, dialysis machine, catheter, and graft. Furthermore, the report excludes revenue generated from post-sale services of hemodialysis and peritoneal dialysis devices and consumables.

Medical simulation is a modern technology for training of healthcare professionals using advanced educational technology. The study provides dynamics and trends of the global medical simulation market. In addition, it includes the market estimations and forecasts from 2020 to 2027. The report includes revenue generated from various medical simulators sold in the market, but excludes revenue generated by dealers, traders, or brokers involved in the supply chain of simulators.

The global genetic counseling market has witnessed significant growth, attributing to the increasing demand for genetic counseling in both risk assessment and pharmacogenomics settings. In both settings, the findings identified through genetic counseling have been instrumental in improving the disease risk assessment, quality of life, and reducing the cost and time of the treatment. Further, the increasing awareness and adoption of the precision therapeutics and diagnostic approach in the developed and the developing countries is the key driver for the growth of the global genetic counseling market.

Herbal nutraceuticals are obtained from natural sources with no added chemicals or toxins. These products are highly effective, safer, and more tolerable as compared to conventional products available in the market. They help in maintaining health and act against nutritionally induced acute and chronic diseases, which promotes optimal health, longevity, and quality of life. Some common herbal nutraceuticals available in the market include aloe vera, ginger, garlic, green tea, and turmeric. The global herbal nutraceuticals market is analyzed on the basis of its prospects and future growth rate. The report highlights numerous factors that influence growth of the market. These include market forecast, drivers, restraints, opportunities, and role of different key players operating in the market. The report is analyzed for herbal nutraceuticals by product type including aloe vera, ginger, garlic, green tea, turmeric, and others. In addition, it focuses on the nature segment, which includes conventional and organics.

The healthcare payer solution can be defined as the services provided by the healthcare IT companies to payers, i.e. private and public insurers as well as insurance companies, to help with streamlining the business processes and reduce operational cost. The report provides market dynamics and trends related to the global healthcare payer solution market. In addition, it presents the market estimations and forecast. For the purpose of analysis, the global healthcare payer solution market is segmented into service, application, provider, and region. The study estimates revenue generated from the sale of services such as business process outsourcing services, information technology outsourcing services, and knowledge process outsourcing services. The applications covered in the study include pharmacy audit & analysis systems, claims management services, fraud management services, computer-assisted coding (CAC) systems, member eligibility management services, provider network management services, payment management services, customer relationship management services, medical document management services, and general ledger & payroll management. Moreover, the report covers revenue generated from the sales of healthcare payer solution offered in regions such as North America, Europe, Asia-Pacific, and LAMEA

The global infectious disease biomarker testing market is witnessing a significant flux with regard to the recent advancements that have already taken place and are currently invading the market space. Additionally, with the entry of large number of companies in the market and launch of new product lines, the market represents massive potential to grow at an unprecedented double-digit growth rate. Factors such as increasing prevalence of infectious diseases, rapidly growing aging population that is more susceptible to disease, rising healthcare awareness, and the increasing involvement of patients in personal healthcare are collectively driving the growth the global infectious disease biomarker testing market. Further, technological advancements improving the ability to analyze the increasing number of biomarkers coupled with the augmenting demand for biomarker tests to diagnose various types of infectious diseases are some of the prominent driving factors accelerating the growth of the market.

The nutrition and supplement industry has begun witnessing the real-life benefits of the eubiotics products in applications such as improving animals’ immune power, promoting efficient gut health, overall performance, nutrient uptake, and reducing the pathogenic and undesirable bacteria. Moreover, eubiotics products and ingredients have been amongst the most researched and developed products in the nutrition and supplement industry in the past five years. Popularly, the eubiotics products and ingredients in the industry are offered as probiotics, prebiotics, organic acids, and essential oils. This section of the study discusses all the eubiotics type offerings in the market in detail. Presently, the product and ingredient offerings in the market include probiotics, prebiotics, organic acids, and essential oils, as illustrated in the following figure.

The global liquid biopsy market has witnessed significant growth, attributing to the increasing demand for less invasive biopsies and other monitoring approaches while treating cancer patients. Liquid biopsies had also been instrumental in other settings including early screening, treatment decision, redesigning treatment approaches, and prenatal screening. Further, the increasing utilization of the non-invasive biopsy procedures in the developed and the developing countries is the key driver for the growth of the global liquid biopsy market.

Digital polymerase chain reaction (d-PCR) is considered a next-generation PCR technology offering rapid, sensitive quantification of nucleic acid when compared to the conventional PCR technology. Digital PCR is highly precise, where each sample partitioned into a number of individualized reactions or as droplets in a droplet-based digital PCR. These partitioned droplets are analyzed after a separate PCR reaction takes place per single sample, and the absolute number of molecules present in the sample is calculated. In the droplet digital PCR, the sample partitioning enables precise detection of single template molecules and specific quantification while mitigating the effects of target competition, reducing the PCR bias, and improving the sensitivity of the assays. Digital PCR offers significant benefits over other PCR methods and is considered a new approach to nucleic acid detection and quantification. Due to the absolute quantification of biological samples, this technique has found its application in various clinical areas, such as rare mutation detection, copy number variation, liquid biopsy, gene expression, miRNA analysis, single-cell analysis, pathogen detection, and next-generation sequencing (NGS) library analysis.

行业观点：我国新冠疫苗研发进度喜人，产品上市可期。截至目前，全球新冠病毒疫苗共有10 个进入III 期临床，其中我国有4 个进入III 期临床，处于全球前列。10 月15 日，浙江嘉兴市疾控中心在其官方微信“嘉兴疾控”发布《新冠疫苗接种的有关说明》，其中提到新冠疫苗接种可用于紧急接种。共需接种2 剂次，间隔14-28 天，疫苗价格为200 元/支，2 剂次共400 元。我们认为未来产品正式上市 ，价格将在400 元/人左右。

不同于传统小分子药物和抗体药物在蛋白质水平进行调控，基因治疗可以在DNA 或mRNA 水平上对致病基因进行修正从而达到治疗效果，可以绕过传统小分子和抗体成药性上的难点不足、极大扩展可能要潜在靶点，对于致病基因清晰而蛋白质水平难以成药的靶点具有独特优势，如RAS、AKT、MYC 等。

不管是小分子化药，还是大分子单抗，它们结合靶点蛋白的分子都基于 三维空间上构象的契合，这就会导致药物的筛选过程是高度非标准化 的，有时候甚至会带有偶然的运气成分。小核酸药物的开发则完全不同， 原则上只需要针对小核酸药物的基因开发合适的序列，就可以开发成为 新的药物。这一设计过程避免了研发过程中的盲目性，一旦确定了小核 酸药物的靶标序列后，其筛选流程相对较快，耗时明显更短，而且小核 酸药物的生物特异性也是非常高的。

罗氏公司公布2020 年三季报。2020 年前三季度公司合计收入439.79 亿瑞士法郎，同比增长1%。分季度看：Q1 开年总体增长强劲；Q2 受疫情、封城令等影响，增速放缓，需要在院内使用的品种承压较大；Q3 业绩复苏，特别是新药以及新冠相关的诊断产品表现靓眼；公司预计Q4 业绩将会继续复苏。分产品类型来看：药品板块收入为343.17 亿瑞士法郎，同比降低1%，新药高速增长抵消了大部分生物类似药带来的负面影响。体外诊断板块收入96.62 亿瑞士法郎，同比增长9%，增长动力主要来自于新冠相关检测业务。文章内容来自罗氏2020 三季报业绩会议。

近日，联合采购办公室发布《国家组织冠脉支架集中带量采购文件》，本次采购冠脉支架品种为钴铬合金或铂铬合金材质，载药种类为雷帕霉素及其衍生物，首年意向采购总量为1074722 个，采购周期为2 年，每年签订采购协议，采购竞价日期为2020 年11 月5 日。

行情回顾：10.12-10.25 期间，医药生物板块涨幅为-2.75%，在所有板块中位列第二十二位，跑输沪深300 指数3.82 个百分点；年初至今，医药生物板块涨幅为46.14%，跑赢沪深300指数31.05 个百分点。

10 月16 日，国家联采办印发《国家组织冠脉支架集中带量采购文件》。

本周生物医药指数下跌6.24%，板块表现差于沪深300 的1.53%的跌幅。医药龙头业绩较优，为何涨不动反而跌？主要原因有三：其一市场波动较大挣钱效应弱；其二受到心脏支架带量采购及11 月份新药医保谈判不确定性影响；其三医药板块年初至今获益丰厚，超额收益明显。但我们认为：十月份医药板块会扭转前二个月颓势吗？维持结构化盘整上行观点不变。原因有三，其一Q3 业绩窗口期、业绩好，各子行业龙头3 季度报业绩持续恢复，整体预期较好；其二海外疫苗形势较为严峻，将为国内疫情防护及筛查标的公司业绩更加具有持续性；其三国内外疫苗研发或将有新进展，催化医疗板块持续走强。